# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-008841
Filing Date
2020-07-31
Accepted
2020-07-31 09:00:47
Documents
57
Period of Report
2020-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | glyc-20200630x10q.htm iXBRL | 10-Q | 1317585
2 | EX-31.1 | glyc-20200630xex31d1.htm | EX-31.1 | 17009
3 | EX-31.2 | glyc-20200630xex31d2.htm | EX-31.2 | 16830
4 | EX-32.1 | glyc-20200630xex32d1.htm | EX-32.1 | 9437
| Complete submission text file | 0001558370-20-008841.txt |  | 5114083

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | glyc-20200630.xsd | EX-101.SCH | 29126
6 | EX-101.CAL | glyc-20200630_cal.xml | EX-101.CAL | 37491
7 | EX-101.DEF | glyc-20200630_def.xml | EX-101.DEF | 141190
8 | EX-101.LAB | glyc-20200630_lab.xml | EX-101.LAB | 282743
9 | EX-101.PRE | glyc-20200630_pre.xml | EX-101.PRE | 269168
10 | EXTRACTED XBRL INSTANCE DOCUMENT | glyc-20200630x10q_htm.xml | XML | 905358

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 201063866
SIC: 2834 Pharmaceutical Preparations